A Study to Assess Safety, Tolerability and Drug Levels of BMS-986504 in Participants With Advanced Solid Tumors

NCT07077434 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
32
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb